CFU

Sports Diplomacy: Uzbekistan Ambassador Invites UK and Uzbek Cricketers for Talks

Retrieved on: 
Monday, January 22, 2024
Woman, University, Bat, CFU, ICC, University of Warwick, Athlete, CIS, Government, Sport, Growth, Oval, Usmanov, MBA, Fergana Valley, Aptitude, Interest, International Cricket Council, Atmosphere, Century, Sports equipment

LONDON, Jan. 22, 2024 /PRNewswire/ -- In what has become his trademark style, recently appointed Uzbekistan Ambassador Ravshan Usmanov today continued his high-energy round of get-acquainted meetings with key people in unusual fields by bringing together cricketers from the UK and from his homeland to discuss how their sport serves the bilateral relationship.

Key Points: 
  • But he has also been inviting spokesmen for more surprising corners of society to discuss their current relationships with Uzbekistan.
  • A businessman, with an MBA from Warwick University, Mr. Mihliev says cricket is the fastest growing sport in Uzbekistan.
  • "We have high expectations of the UK helping Uzbek cricket rise quickly to professional levels," he said.
  • Both Mr. Gaffney and Mr. Mihliev paid credit to Sophie Ibbotson, a UK brand ambassador for the Uzbekistan Tourism Committee, for bringing them together.

Sports Diplomacy: Uzbekistan Ambassador Invites UK and Uzbek Cricketers for Talks

Retrieved on: 
Monday, January 22, 2024
Woman, University, Bat, CFU, ICC, University of Warwick, Athlete, CIS, Government, Sport, Growth, Oval, Usmanov, MBA, Fergana Valley, Aptitude, Interest, International Cricket Council, Atmosphere, Century, Sports equipment

LONDON, Jan. 22, 2024 /PRNewswire/ -- In what has become his trademark style, recently appointed Uzbekistan Ambassador Ravshan Usmanov today continued his high-energy round of get-acquainted meetings with key people in unusual fields by bringing together cricketers from the UK and from his homeland to discuss how their sport serves the bilateral relationship.

Key Points: 
  • But he has also been inviting spokesmen for more surprising corners of society to discuss their current relationships with Uzbekistan.
  • A businessman, with an MBA from Warwick University, Mr. Mihliev says cricket is the fastest growing sport in Uzbekistan.
  • "We have high expectations of the UK helping Uzbek cricket rise quickly to professional levels," he said.
  • Both Mr. Gaffney and Mr. Mihliev paid credit to Sophie Ibbotson, a UK brand ambassador for the Uzbekistan Tourism Committee, for bringing them together.

Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System

Retrieved on: 
Wednesday, January 10, 2024
TTD, CFU, USP, Commercial, Sale, Automation, 3D printing

LOWELL, Mass., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it expects the commercial launch of the Growth Direct Rapid Sterility application by mid-year 2024.

Key Points: 
  • The Company has developed a novel, proprietary Rapid Sterility application for use with its Growth Direct system.
  • “We are extremely excited about the data and the results we have achieved with our new Growth Direct Rapid Sterility application – this is truly a breakthrough technology,” said Robert Spignesi, President and CEO of Rapid Micro Biosystems.
  • In addition, we expect that the Growth Direct Rapid Sterility application will enable faster release of final pharmaceutical product, allowing manufacturers to benefit from faster time to market, less potential waste and reduced inventory and holding costs.
  • Commercial launch of the Growth Direct Rapid Sterility application is expected by mid-year 2024.

BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, November 14, 2023
Webcast, Drug development, Disease, NESS, Safety, NYSE, Policy, Senior, Food, Cystic fibrosis, Plasma protein binding, H.262/MPEG-2 Part 2, Workforce, Sputum, Clinical trial, Mortality, Insurance, Patient, Research, Part, FDA, Pharmacokinetics, Bacteria, Novartis, Conference, Pseudomonas aeruginosa, FEV1, Communication, CFU, Dermatology, Physician, Psoriatic arthritis, Fast Track, Part Two, Pharmaceutical industry, Medical imaging, Cryptocurrency

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the third quarter ended September 30, 2023.

Key Points: 
  • and NESS ZIONA, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the third quarter ended September 30, 2023.
  • In addition, the U.S. Food and Drug Administration recently granted Fast Track designation for BX004, further underscoring the potential of this promising program.
  • Net loss for the third quarter of 2023 was $7.9 million, compared to $6.8 million for the same period in 2022.
  • Net cash used in operating activities for the nine months ended September 30, 2023, was $15.0 million, compared to $21.9 million for the same period in 2022.

Not Just Yogurt Anymore

Retrieved on: 
Thursday, October 26, 2023
CFU, Meal, Drink, Food court, Novozymes, Snack, Coffee, Cell, Probiotic, Functional food, Bacillus subtilis, Food, Dietary supplement

FRANKLINTON, N.C., Oct. 26, 2023 /PRNewswire/ -- Novozymes is excited to launch ProSilience™ HU58, a probiotic with superior stability and low cost-in-use that may help change the way America eats breakfast (and snacks and other meals).

Key Points: 
  • The probiotic can withstand harsh processing conditions, allowing it to become an ingredient in entirely new food categories – for example, breakfast cereal or coffee.
  • "ProSilience™ HU58 provides the clinically supported digestive and immune benefits that consumers demand," says Stephen Quinn, Novozymes Industry Manager, Functional Foods.
  • The new product is a part of Novozymes' commitment to driving innovation in biosolutions and promoting healthy, sustainable food choices.
  • Easy handling: ProSilience™ HU58 is easy to formulate, easy to incorporate into existing production lines, and supported by Novozymes Technical Service.

ILiAD Biotechnologies Reports First-ever Demonstration of Protection Against B. pertussis Colonization in Phase 2b Human Challenge Study of BPZE1 Vaccine

Retrieved on: 
Tuesday, September 5, 2023
Other Health, Research, General Health, Pharmaceutical, Infectious Diseases, Hospitals, Clinical Trials, Science, Biotechnology, FDA, Other Science, Health, Vaccine, Bordetella pertussis, Cold medicine, University Hospital Southampton NHS Foundation Trust, University, Vaccination, Culture, Public, Immunity, Infection, CFU, CDC, Epidemic, Quarantine, Death, Congress, Professor, CFU-GEMM, Clutch (eggs), United Kingdom, Iliad, Immunization, University of Oxford, Safety, Disease, MD

ILiAD Biotechnologies reported today that its BPZE1 intranasal pertussis vaccine has met the primary endpoint of protection against nasopharyngeal B. pertussis colonization (p=0.03) in the Phase 2b CHAMPION-1 Study.

Key Points: 
  • ILiAD Biotechnologies reported today that its BPZE1 intranasal pertussis vaccine has met the primary endpoint of protection against nasopharyngeal B. pertussis colonization (p=0.03) in the Phase 2b CHAMPION-1 Study.
  • The CHAMPION-1 Phase 2b Human Challenge study is a randomized, double-blind, placebo-controlled study of BPZE1 vaccine in healthy adults.
  • The study has a primary objective to demonstrate that prior immunization with BPZE1 protects against colonization as evidenced by negative B. pertussis culture following virulent B. pertussis challenge 2–4 months after vaccination.
  • As a result, the preparation method of the B. pertussis challenge dose was modified to achieve the per-protocol adequate inoculum of B. pertussis challenge as specified in the original study protocol.

Peloton Kicks Off College Strategy Engaging Students, Athletes, and Alumni

Retrieved on: 
Tuesday, August 22, 2023
University, Gen, Magic, Social media, CFU, Generation Z, Athlete, Student, Medical Academy named after S.I. Georgievsky of Vernadsky CFU, Peloton Interactive, Bicycle, Health, Exercise, Sport, Nursing

Finally, Peloton will also partner to create opportunities for alumni and fans to experience related benefits.

Key Points: 
  • Finally, Peloton will also partner to create opportunities for alumni and fans to experience related benefits.
  • Additionally, Peloton offers K-12 US teachers, college educators, and administrators access to discounted offers for its world class connected fitness portfolio.
  • Peloton is excited to be a part of their journey," said Dion Camp Sanders, Peloton Chief Emerging Business Officer.
  • "By merging our expertise, athletic fandom, and college communities at-large, we aim to support and inspire students, alumni, and college communities to achieve their fitness ambitions."

BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, August 9, 2023
Insurance, Communication, CFA, Cystic fibrosis, Data analysis, Patient, Cystic Fibrosis Foundation, Disease, NYSE, PIPE, Policy, Pharmacokinetics, CFU, Pseudomonas aeruginosa, Corporation, Bacteria, Treasurer, FDA, CF, Conference, Safety, International, Professional corporation, ECFC, Psoriatic arthritis, Mortality, Research, Therapy, FEV1, Sputum, Workforce, Drug development, Clinical trial, Urinary tract infection, Fast Track, Part, Plasma protein binding, NESS, Phage therapy, Poster, AD, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Biogen, Pharmaceutical industry, Medical imaging, Cryptocurrency

CAMBRIDGE, Mass. and NESS ZIONA, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the second quarter ended June 30, 2023.

Key Points: 
  • and NESS ZIONA, Israel, Aug. 09, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the second quarter ended June 30, 2023.
  • “Our BX004 clinical program in cystic fibrosis (“CF”) continues to build significant momentum,” said Jonathan Solomon, Chief Executive Officer of BiomX.
  • Net loss for the second quarter of 2023 was $6.4 million, compared to $7.5 million for the same period in 2022.
  • BiomX management will host a conference call and webcast today at 8:00 am ET to report financial results and business updates for the second quarter of 2023.

JYM Supplement Science launches JYM ProBio on JYMSupps.com and Amazon

Retrieved on: 
Saturday, July 22, 2023
Exercise, Heart, Science, Body composition, Digestion, Woman, Facial muscles, CFU, JYM, Amazon (company), Probiotic, Athlete, Dietary supplement, Amazon

WESTLAKE VILLAGE, Calif., July 22, 2023 /PRNewswire-PRWeb/ -- JYM Supplement Science and Dr. Jim Stoppani have officially entered the probiotics category with the introduction of JYM ProBio – now available at both JYMSupps.com and Amazon.com.

Key Points: 
  • WESTLAKE VILLAGE, Calif., July 22, 2023 /PRNewswire-PRWeb/ -- JYM Supplement Science and Dr. Jim Stoppani have officially entered the probiotics category with the introduction of JYM ProBio – now available at both JYMSupps.com and Amazon.com .
  • JYM ProBio is an "all in one" probiotic supplement featuring 11 different probiotic strains, totaling 10 billion CFU, to help promote healthy gut function, heart and immune health, neurotransmitter balance, and more.
  • "Athletes and hard-training individuals have specific supplemental needs," says Dr. Stoppani, co-owner and formulator of JYM Supplement Science.
  • JYM ProBio is currently available for purchase at both JYMSupps.com and Amazon .

The Nutraceutical Brand Emphasizing Tangible Results for Real-World Problems

Retrieved on: 
Wednesday, May 24, 2023
Motivation, Fatigue, System, Growth, Sharp, Health, Immunity, Probiotic, Antioxidant, CFU, Sea Power, Dietary supplement

FORT LAUDERDALE, Fla., May 24, 2023 /PRNewswire/ -- The nutraceutical market is massive. It was valued at nearly $400 billion in 2021 and is expected to reach nearly $650 billion by 2030. Much of this growth is pushed by informed consumers looking for safe, natural ways to enhance their health using food-based supplements.

Key Points: 
  • Much of this growth is pushed by informed consumers looking for safe, natural ways to enhance their health using food-based supplements.
  • While the motivation and focus on nutraceutical health is overall a good thing, those same consumers often find it challenging to find the supplements they need.
  • They struggle to discover brands they can trust to create targeted supplement solutions that produce effective results for their specific problems.
  • Oomph Body is a brand that is committed to product innovation in the name of targeting, adapting to, and meeting consumer health needs.